Medindia
Medindia LOGIN REGISTER
Advertisement

For the Treatment of Moderate to Severe Alzheimer's Disease, a Combination Treatment That Delays Nursing Home Admission Would Earn Higher Patient Share in the U.S. Than Europe

Wednesday, February 17, 2010 General News
Advertisement
The Dimebon Plus Aricept Combination Will Become Decision Resources' Proprietary Clinical Gold Standard for the Treatment of Moderate to Severe Alzheimer's Disease in 2013

For more information, contact:

Gisselle Morales

Elizabeth Marshall

Decision Resources

Decision Resources, Inc.

781-296-2691

781-296-2563

[email protected]

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close